Dublin, Feb. 17, 2017 -- Research and Markets has announced the addition of the "Pharmaceutical Contract Manufacturing - Global Strategic Business Report" report to their offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Pharmaceutical Contract Manufacturing in US$ Thousand by the following Dosage Forms:
- Injectables
- Solid Dosage Forms
- Liquid & Semi-solid Dosage Forms
The report profiles 112 companies including many key and niche players such as
- Aenova Group (Germany)
- Ajinomoto Althea, Inc. (US)
- Albany Molecular Research Inc. (US)
- Alcami Corporation (US)
- Baxter International, Inc. (US)
- Boehringer Ingelheim GmbH (Germany)
- Catalent Pharma Solutions, Inc. (US)
- Cobra Biologics Holding AB (Sweden)
- CordenPharma International (Germany)
- Dishman Group (India)
- DPx Holdings B.V. (US)
- Fareva Group (Luxembourg)
- Famar Health Care Services (Greece)
- Hospira, Inc. (US)
- Jubilant Life Sciences Limited (India)
- Kemwell Biopharma Pvt. Ltd. (India)
- Lonza Group Ltd. (Switzerland)
- LTS Lohmann Therapie-Systeme AG (Germany)
- NextPharma Technologies Holding Ltd. (UK)
- Nipro Pharma Corporation (Japan)
- Recipharm AB (Sweden)
- Vetter Pharma International GmbH (Germany)
Key Topics Covered:
1. Industry Overview
2. Market Trends & Drivers
3. Competitive Landscape
4. Service Overview
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 112 (including Divisions/Subsidiaries 125)
- The United States (54)
- Canada (2)
- Japan (7)
- Europe (40)
- - France (6)
- - Germany (10)
- - The United Kingdom (7)
- - Italy (3)
- - Spain (2)
- - Rest of Europe (12)
- Asia-Pacific (Excluding Japan) (21)
- Middle East (1)
For more information about this report visit http://www.researchandmarkets.com/research/ptddk8/pharmaceutical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Pharmaceuticals, Pharmaceutical Manufacturing


Chinese Brands Are Taking Over Brazil — And It's Just Getting Started
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization
NIO ES9 SUV Launch Sends HK Shares Down 7% Despite Bold Pricing Strategy
Chinese Cars in Europe: Consumer Trust Is Shifting Fast
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
Meta Is Building an AI Version of Mark Zuckerberg to Interact With Employees
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58%
San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home
Pony.ai, Uber, and Verne Launch Europe's First Commercial Robotaxi Service in Zagreb 



